484 related articles for article (PubMed ID: 24511121)
1. Thrombospondin-1 activation of signal-regulatory protein-α stimulates reactive oxygen species production and promotes renal ischemia reperfusion injury.
Yao M; Rogers NM; Csányi G; Rodriguez AI; Ross MA; St Croix C; Knupp H; Novelli EM; Thomson AW; Pagano PJ; Isenberg JS
J Am Soc Nephrol; 2014 Jun; 25(6):1171-86. PubMed ID: 24511121
[TBL] [Abstract][Full Text] [Related]
2. Deficiency in SIRP-α cytoplasmic recruitment confers protection from acute kidney injury.
Ghimire K; Chiba T; Minhas N; Meijles DN; Lu B; O'Connell P; Rogers NM
FASEB J; 2019 Oct; 33(10):11528-11540. PubMed ID: 31370677
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1.
Csányi G; Yao M; Rodríguez AI; Al Ghouleh I; Sharifi-Sanjani M; Frazziano G; Huang X; Kelley EE; Isenberg JS; Pagano PJ
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2966-73. PubMed ID: 23087362
[TBL] [Abstract][Full Text] [Related]
4. Activation of parenchymal CD47 promotes renal ischemia-reperfusion injury.
Rogers NM; Thomson AW; Isenberg JS
J Am Soc Nephrol; 2012 Sep; 23(9):1538-50. PubMed ID: 22859854
[TBL] [Abstract][Full Text] [Related]
5. The role of CD47 in pathogenesis and treatment of renal ischemia reperfusion injury.
Isenberg JS; Roberts DD
Pediatr Nephrol; 2019 Dec; 34(12):2479-2494. PubMed ID: 30392076
[TBL] [Abstract][Full Text] [Related]
6. Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its management.
Rogers NM; Yao M; Novelli EM; Thomson AW; Roberts DD; Isenberg JS
Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1117-25. PubMed ID: 22874763
[TBL] [Abstract][Full Text] [Related]
7. CD47 regulates renal tubular epithelial cell self-renewal and proliferation following renal ischemia reperfusion.
Rogers NM; Zhang ZJ; Wang JJ; Thomson AW; Isenberg JS
Kidney Int; 2016 Aug; 90(2):334-347. PubMed ID: 27259369
[TBL] [Abstract][Full Text] [Related]
8. The potentiating effect of hTFPI in the presence of hCD47 reduces the cytotoxicity of human macrophages.
Jung SH; Hwang JH; Kim SE; Young Kyu K; Park HC; Lee HT
Xenotransplantation; 2017 May; 24(3):. PubMed ID: 28393401
[TBL] [Abstract][Full Text] [Related]
9. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1.
Isenberg JS; Ridnour LA; Dimitry J; Frazier WA; Wink DA; Roberts DD
J Biol Chem; 2006 Sep; 281(36):26069-80. PubMed ID: 16835222
[TBL] [Abstract][Full Text] [Related]
10. Thrombospondin-1-CD47 blockade and exogenous nitrite enhance ischemic tissue survival, blood flow and angiogenesis via coupled NO-cGMP pathway activation.
Isenberg JS; Shiva S; Gladwin M
Nitric Oxide; 2009 Aug; 21(1):52-62. PubMed ID: 19481167
[TBL] [Abstract][Full Text] [Related]
11. SIRP-alpha-CD47 system functions as an intercellular signal in the renal glomerulus.
Kurihara H; Harita Y; Ichimura K; Hattori S; Sakai T
Am J Physiol Renal Physiol; 2010 Sep; 299(3):F517-27. PubMed ID: 20554646
[TBL] [Abstract][Full Text] [Related]
12. Integrin-associated protein binding domain of thrombospondin-1 enhances insulin-like growth factor-I receptor signaling in vascular smooth muscle cells.
Maile LA; Clemmons DR
Circ Res; 2003 Nov; 93(10):925-31. PubMed ID: 14563713
[TBL] [Abstract][Full Text] [Related]
13. Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1.
Bauer PM; Bauer EM; Rogers NM; Yao M; Feijoo-Cuaresma M; Pilewski JM; Champion HC; Zuckerbraun BS; Calzada MJ; Isenberg JS
Cardiovasc Res; 2012 Mar; 93(4):682-93. PubMed ID: 22215724
[TBL] [Abstract][Full Text] [Related]
14. Differential interactions of thrombospondin-1, -2, and -4 with CD47 and effects on cGMP signaling and ischemic injury responses.
Isenberg JS; Annis DS; Pendrak ML; Ptaszynska M; Frazier WA; Mosher DF; Roberts DD
J Biol Chem; 2009 Jan; 284(2):1116-25. PubMed ID: 19004835
[TBL] [Abstract][Full Text] [Related]
15. Is CD47 a potentially promising therapeutic target in cardiovascular diseases? - Role of CD47 in cardiovascular diseases.
Cheng Q; Gu J; Adhikari BK; Sun L; Sun J
Life Sci; 2020 Apr; 247():117426. PubMed ID: 32061866
[TBL] [Abstract][Full Text] [Related]
16. CD47 in the immune response: role of thrombospondin and SIRP-alpha reverse signaling.
Sarfati M; Fortin G; Raymond M; Susin S
Curr Drug Targets; 2008 Oct; 9(10):842-50. PubMed ID: 18855618
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer.
Roberts DD; Kaur S; Isenberg JS
Antioxid Redox Signal; 2017 Oct; 27(12):874-911. PubMed ID: 28712304
[TBL] [Abstract][Full Text] [Related]
18. Blocking thrombospondin-1 signaling via CD47 mitigates renal interstitial fibrosis.
Julovi SM; Sanganeria B; Minhas N; Ghimire K; Nankivell B; Rogers NM
Lab Invest; 2020 Sep; 100(9):1184-1196. PubMed ID: 32366943
[TBL] [Abstract][Full Text] [Related]
19. Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration.
Liu Y; Bühring HJ; Zen K; Burst SL; Schnell FJ; Williams IR; Parkos CA
J Biol Chem; 2002 Mar; 277(12):10028-36. PubMed ID: 11792697
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin-1 differentially induces chemotaxis and DNA synthesis of human venous smooth muscle cells at the receptor-binding level.
Lymn JS; Patel MK; Clunn GF; Rao SJ; Gallagher KL; Hughes AD
J Cell Sci; 2002 Nov; 115(Pt 22):4353-60. PubMed ID: 12376566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
